![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SLC37A3 | Human | (1->4)-beta-D-glucan | multiple interactions | ISO | Slc37a3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC37A3 mRNA | CTD | PMID:36331819 | SLC37A3 | Human | 1,2-dichloroethane | decreases expression | ISO | Slc37a3 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of SLC37A3 mRNA | CTD | PMID:28960355 | SLC37A3 | Human | 1,2-dimethylhydrazine | multiple interactions | ISO | Slc37a3 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC37A3 mRNA | CTD | PMID:22206623 | SLC37A3 | Human | 17beta-estradiol | multiple interactions | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of SLC37A3 mRNA | CTD | PMID:26496021 | SLC37A3 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of SLC37A3 mRNA | CTD | PMID:31614463 | SLC37A3 | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Slc37a3 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | SLC37A3 | Human | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLC37A3 mRNA | CTD | PMID:33387578 | SLC37A3 | Human | 4,4'-sulfonyldiphenol | increases methylation | ISO | Slc37a3 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of SLC37A3 promoter | CTD | PMID:33297965 | SLC37A3 | Human | 6-propyl-2-thiouracil | increases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of SLC37A3 mRNA | CTD | PMID:30047161 | SLC37A3 | Human | acrolein | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SLC37A3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | CTD | PMID:32699268 | SLC37A3 | Human | acrylamide | increases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | Acrylamide results in increased expression of SLC37A3 mRNA | CTD | PMID:28959563 | SLC37A3 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SLC37A3 mRNA | CTD | PMID:33167477 | SLC37A3 | Human | alpha-pinene | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SLC37A3 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of and results in increased oxidation of SLC37A3 mRNA | CTD | PMID:32699268 | SLC37A3 | Human | amitrole | increases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | Amitrole results in increased expression of SLC37A3 mRNA | CTD | PMID:30047161 | SLC37A3 | Human | amphetamine | increases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of SLC37A3 mRNA | CTD | PMID:30779732 | SLC37A3 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of SLC37A3 mRNA | CTD | PMID:24449571 | SLC37A3 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of SLC37A3 promoter | CTD | PMID:27901495 | SLC37A3 | Human | beta-lapachone | increases expression | EXP | | 6480464 | beta-lapachone results in increased expression of SLC37A3 mRNA | CTD | PMID:38218311 | SLC37A3 | Human | bisphenol A | multiple interactions | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with Estradiol] results in decreased expression of SLC37A3 mRNA | CTD | PMID:26496021 | SLC37A3 | Human | bisphenol A | decreases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLC37A3 mRNA | CTD | PMID:30816183 | SLC37A3 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of SLC37A3 mRNA | CTD | PMID:38568856 | SLC37A3 | Human | copper atom | increases expression | ISO | Slc37a3 (Mus musculus) | 6480464 | Copper results in increased expression of SLC37A3 mRNA | CTD | PMID:16629173 | SLC37A3 | Human | copper(0) | increases expression | ISO | Slc37a3 (Mus musculus) | 6480464 | Copper results in increased expression of SLC37A3 mRNA | CTD | PMID:16629173 | SLC37A3 | Human | cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of SLC37A3 mRNA | CTD | PMID:25562108 | SLC37A3 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of SLC37A3 mRNA | CTD | PMID:37042841 | SLC37A3 | Human | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of SLC37A3 mRNA | CTD | PMID:28302478 | SLC37A3 | Human | dioxygen | multiple interactions | ISO | Slc37a3 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC37A3 mRNA | CTD | PMID:30529165 | SLC37A3 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SLC37A3 mRNA | CTD | PMID:29803840 | SLC37A3 | Human | ethanol | affects splicing | ISO | Slc37a3 (Mus musculus) | 6480464 | Ethanol affects the splicing of SLC37A3 mRNA | CTD | PMID:30319688 | SLC37A3 | Human | folic acid | multiple interactions | ISO | Slc37a3 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC37A3 mRNA | CTD | PMID:22206623 | SLC37A3 | Human | gentamycin | decreases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SLC37A3 mRNA | CTD | PMID:33387578 | SLC37A3 | Human | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of SLC37A3 mRNA | CTD | PMID:22714537 | SLC37A3 | Human | ozone | multiple interactions | EXP | | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of and results in increased oxidation of SLC37A3 mRNA more ... | CTD | PMID:32699268 | SLC37A3 | Human | paracetamol | affects expression | ISO | Slc37a3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SLC37A3 mRNA | CTD | PMID:17562736 | SLC37A3 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Slc37a3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SLC37A3 mRNA | CTD | PMID:36331819 | SLC37A3 | Human | propiconazole | increases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | propiconazole results in increased expression of SLC37A3 mRNA | CTD | PMID:30047161 | SLC37A3 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of SLC37A3 mRNA | CTD | PMID:23557933 | SLC37A3 | Human | sulfadimethoxine | increases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | Sulfadimethoxine results in increased expression of SLC37A3 mRNA | CTD | PMID:30047161 | SLC37A3 | Human | sulforaphane | multiple interactions | ISO | Slc37a3 (Mus musculus) | 6480464 | [sulforaphane affects the susceptibility to Oxygen] which affects the expression of SLC37A3 mRNA | CTD | PMID:30529165 | SLC37A3 | Human | T-2 toxin | decreases expression | EXP | | 6480464 | T-2 Toxin results in decreased expression of SLC37A3 mRNA | CTD | PMID:31863870 | SLC37A3 | Human | tetrachloromethane | affects expression | ISO | Slc37a3 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of SLC37A3 mRNA | CTD | PMID:17484886 | SLC37A3 | Human | tetrachloromethane | decreases expression | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of SLC37A3 mRNA | CTD | PMID:31150632 | SLC37A3 | Human | titanium dioxide | decreases methylation | ISO | Slc37a3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SLC37A3 promoter alternative form | CTD | PMID:35295148 | SLC37A3 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of SLC37A3 mRNA | CTD | PMID:37042841 | SLC37A3 | Human | triptonide | decreases expression | ISO | Slc37a3 (Mus musculus) | 6480464 | triptonide results in decreased expression of SLC37A3 mRNA | CTD | PMID:33045310 | SLC37A3 | Human | valproic acid | affects splicing | ISO | Slc37a3 (Rattus norvegicus) | 6480464 | Valproic Acid affects the splicing of SLC37A3 mRNA | CTD | PMID:29427782 | |